STREFEN 8.75 mg, lozenge 16 lozenges
Active ingredients: (±)-flurbiprofen
Commercialized according to BDPMDispensing in France: Prescription only
Lozenge16 lozengesvoie buccale autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- STREFEN 8,75 mg, pastille
- Pharmaceutical form
- pastille
- Route of administration
- voie buccale autre
- Presentation description
- plaquette(s) thermoformée(s) PVC-aluminium PVDC de 16 pastille(s)
- Marketing authorisation holder
- RECKITT BENCKISER HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 20 Oct 2025
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65407780CIP73543600CIP133400935436009Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FLURBIPROFÈNEpastille | 8,75 mg · une pastille | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.